We are live on
!
Find out more
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
43 hedge funds and large institutions have $154M invested in Sienna Biopharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
125% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 8
26% more funds holding
Funds holding: 34 → 43 (+9)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less capital invested
Capital invested by funds: $178M → $154M (-$23.9M)
Holders
43
Holders Change
+9
Holders Change %
+26.47%
% of All Funds
0.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
18
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$5.92M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.48M |
| 3 |
Morgan Stanley
New York
|
+$1.4M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$1.01M |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$721K |
